Editorial
doi: 10.1002/hep.21391.
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious
- PMID: 17006914
- DOI: 10.1002/hep.21391
Item in Clipboard
Editorial
Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious
Hepatology.
2006 Oct.
No abstract available
Comment on
-
Long-term follow-up of patients with NAFLD and elevated liver enzymes.Hepatology. 2006 Oct;44(4):865-73. doi: 10.1002/hep.21327. Hepatology. 2006. PMID: 17006923
Similar articles
-
[Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].Ned Tijdschr Geneeskd. 2005 Feb 5;149(6):289-94. Ned Tijdschr Geneeskd. 2005. PMID: 15730035 Review. Dutch.
-
Approach to the diagnosis and treatment of nonalcoholic fatty liver disease.Clin Liver Dis. 2005 Nov;9(4):617-34, vi. doi: 10.1016/j.cld.2005.07.002. Clin Liver Dis. 2005. PMID: 16207567 Review.
-
NASH and HCC.Clin Liver Dis. 2009 Nov;13(4):631-47. doi: 10.1016/j.cld.2009.07.007. Clin Liver Dis. 2009. PMID: 19818310
-
Nonalcoholic fatty liver in a developing country is responsible for significant liver disease.Hepatology. 2010 Dec;52(6):2248-9. doi: 10.1002/hep.23838. Epub 2010 Jul 29. Hepatology. 2010. PMID: 20725907 No abstract available.
-
Hepatocellular carcinoma and NASH.J Gastroenterol. 2004;39(4):409-11. doi: 10.1007/s00535-004-1332-y. J Gastroenterol. 2004. PMID: 15168260 No abstract available.
Cited by
-
Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice.Front Pharmacol. 2025 Jan 31;15:1503247. doi: 10.3389/fphar.2024.1503247. eCollection 2024. Front Pharmacol. 2025. PMID: 39958875 Free PMC article.
-
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals.Ann N Y Acad Sci. 2013 Apr;1281(1):106-22. doi: 10.1111/nyas.12016. Epub 2013 Jan 30. Ann N Y Acad Sci. 2013. PMID: 23363012 Free PMC article. Review.
-
Pioglitazone in the treatment of type 2 diabetes: safety and efficacy review.Clin Med Insights Endocrinol Diabetes. 2010;3:43-51. doi: 10.4137/cmed.s5372. Epub 2010 Aug 3. Clin Med Insights Endocrinol Diabetes. 2010. PMID: 22879786 Free PMC article.
-
Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.Nutrients. 2021 Dec 24;14(1):76. doi: 10.3390/nu14010076. Nutrients. 2021. PMID: 35010950 Free PMC article.
-
Mechanisms by which the thiazolidinedione troglitazone protects against sucrose-induced hepatic fat accumulation and hyperinsulinaemia.Br J Pharmacol. 2016 Jan;173(2):267-78. doi: 10.1111/bph.13362. Br J Pharmacol. 2016. PMID: 26447327 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical